Stephanie Lerondel
Overview
Explore the profile of Stephanie Lerondel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
808
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kovalenko A, Eliseeva S, Collet G, El Abdellaoui S, Natkunarajah S, Lerondel S, et al.
J Am Chem Soc
. 2024 May;
146(19):12913-12918.
PMID: 38701376
Near-infrared (NIR) luminescence and photoacoustic (PA) imaging have attracted increasing attention for the real-time monitoring of biological samples due to high sensitivity, resolution, and pronounced signal detection depth, respectively. For...
2.
Folcher A, Gordienko D, Iamshanova O, Bokhobza A, Shapovalov G, Kannancheri-Puthooru D, et al.
EMBO J
. 2023 Jun;
42(13):e112198.
PMID: 37278161
There is growing evidence that ion channels are critically involved in cancer cell invasiveness and metastasis. However, the molecular mechanisms of ion signaling promoting cancer behavior are poorly understood and...
3.
Lacerda S, Zhang W, T M de Rosales R, da Silva I, Sobilo J, Lerondel S, et al.
ACS Appl Mater Interfaces
. 2022 Jul;
PMID: 35830285
Porous materials, such as zeolites, have great potential for biomedical applications, thanks to their ability to accommodate positively charged metal-ions and their facile surface functionalization. Although the latter aspect is...
4.
Grolez G, Chinigo G, Barras A, Hammadi M, Noyer L, Kondratska K, et al.
Int J Mol Sci
. 2022 Jun;
23(12).
PMID: 35743115
In the fight against prostate cancer (PCa), TRPM8 is one of the most promising clinical targets. Indeed, several studies have highlighted that TRPM8 involvement is key in PCa progression because...
5.
Buggisch J, Gohler D, Sobilo J, Lerondel S, Rezniczek G, Stintz M, et al.
BMC Cancer
. 2022 May;
22(1):570.
PMID: 35597921
Background/aim: To develop and validate a nebulizer device for anti-cancer research on pressurized intraperitoneal aerosol supply in a preclinical peritoneal metastases (PM) rat model. Material And Methods: For aerosol generation,...
6.
Gueguinou M, Ibrahim S, Bourgeais J, Robert A, Pathak T, Zhang X, et al.
Cell Mol Life Sci
. 2022 May;
79(6):284.
PMID: 35526196
Background And Aims: Recent evidences highlight a role of the mitochondria calcium homeostasis in the development of colorectal cancer (CRC). To overcome treatment resistance, we aimed to evaluate the role...
7.
Chadet S, Allard J, Brisson L, Lopez-Charcas O, Lemoine R, Heraud A, et al.
Oncogene
. 2022 Apr;
41(21):2920-2931.
PMID: 35411034
Metastatic progression is a major burden for breast cancer patients and is associated with the ability of cancer cells to overcome stressful conditions, such as nutrients deprivation and hypoxia, and...
8.
Rezniczek G, Buggisch J, Sobilo J, Launay A, Lerondel S, Le Pape A, et al.
Cancers (Basel)
. 2020 Dec;
12(12).
PMID: 33348855
Intraperitoneal chemotherapy (IPC) is a locoregional treatment option in patients with peritoneal metastases (PM). Here, we present an ovarian cancer (OC)-derived PM mouse model for the study of different forms...
9.
Brisson L, Chadet S, Lopez-Charcas O, Jelassi B, Ternant D, Chamouton J, et al.
Cancers (Basel)
. 2020 Aug;
12(9).
PMID: 32825056
The P2X7 receptor is an ATP-gated cation channel with a still ambiguous role in cancer progression, proposed to be either pro- or anti-cancerous, depending on the cancer or cell type...
10.
Chatre R, Lange J, Peraudeau E, Poinot P, Lerondel S, Le Pape A, et al.
J Control Release
. 2020 Aug;
327:19-25.
PMID: 32777236
The development of selective anticancer drugs avoiding side effects met in the course of almost all current treatments is of major interest for cancer patients. Here, we report on a...